IDEXX Laboratories, Inc. (IX1.DE)
- Previous Close
497.30 - Open
500.60 - Bid 498.80 x --
- Ask 505.60 x --
- Day's Range
500.60 - 505.00 - 52 Week Range
349.20 - 535.60 - Volume
35 - Avg. Volume
15 - Market Cap (intraday)
41.939B - Beta (5Y Monthly) 1.27
- PE Ratio (TTM)
53.16 - EPS (TTM)
9.50 - Earnings Date Jul 30, 2024 - Aug 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
www.idexx.com11,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: IX1.DE
Performance Overview: IX1.DE
Trailing total returns as of 5/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IX1.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IX1.DE
Valuation Measures
Market Cap
41.30B
Enterprise Value
41.92B
Trailing P/E
52.37
Forward P/E
49.51
PEG Ratio (5yr expected)
5.16
Price/Sales (ttm)
12.18
Price/Book (mrq)
28.45
Enterprise Value/Revenue
12.23
Enterprise Value/EBITDA
36.68
Financial Highlights
Profitability and Income Statement
Profit Margin
23.26%
Return on Assets (ttm)
22.63%
Return on Equity (ttm)
71.91%
Revenue (ttm)
3.72B
Net Income Avi to Common (ttm)
866.57M
Diluted EPS (ttm)
9.50
Balance Sheet and Cash Flow
Total Cash (mrq)
397.43M
Total Debt/Equity (mrq)
68.13%
Levered Free Cash Flow (ttm)
733.09M
Research Analysis: IX1.DE
Company Insights: IX1.DE
IX1.DE does not have Company Insights